Today's Top Health News Story

J&J ordered to pay $417 million in trial over talc cancer risks

(Reuters) - A California jury on Monday ordered Johnson & Johnson to pay $417 million to a woman who claimed she developed ovarian cancer after using the company's talc-based products like Johnson's Baby Powder for feminine hygiene. Learn More

 

More Top Health Stories

AstraZeneca ups investment in messenger RNA drugs with Ethris deal

FRANKFURT (Reuters) - AstraZeneca has stepped up its investment in messenger RNA drugs, a promising approach in genetic therapy, by spending more than 25 million euros ($29 million) on a research alliance with German biotech start-up Ethris. More »

 

Parents still failing to put babies to sleep on their backs

(Reuters Health) - Fewer than half of U.S. infants always sleep on their backs, the position doctors recommend to avoid sleep-related injuries and deaths, a study suggests. More »

 

American surgeons poorly prepared for humanitarian operations

(Reuters Health) - A Haitian physician taught American-trained vascular surgeon Dr. David Kuwayama how to perform C-sections in a Caribbean clinic, and a Congolese surgeon taught him other basic surgical procedures in an African war zone. More »

 

Smokers hospitalized for heart attacks often don't get cessation drugs

(Reuters Health) - Few smokers hospitalized for heart attacks and other serious complications of cardiac disease get medication to help them quit smoking, a U.S. study suggests. More »

 

Belgian biscuit maker recalls products amid contaminated eggs scare

BRUSSELS (Reuters) - Belgian biscuit maker Lotus Bakeries said it had recalled some of its products in Belgium as they could contain eggs that were contaminated with insecticide fipronil. More »

 

U.S. study revives argument over mammogram screening

(Reuters Health) - Yearly mammograms starting at age 40 would prevent the most deaths from breast cancer, U.S. researchers reported on Monday in a challenge to more conservative recommendations that take into account both the harms and the benefits of screening. More »

 

Britain's Creo receives speedy FDA approval for its endoscopic device

LONDON (Reuters) - Britain's Creo Medical Group said its device to remove cancerous lesions in the bowel during an endoscopy had received U.S. approval much quicker than it planned, shaking up a timetable that had been focused on a European launch. More »

 

New Novartis drug takes aim at tough-to-treat malaria

LONDON (Reuters) - Novartis is taking aim at drug-resistant malaria – a growing global problem – by launching clinical trials of the first new antimalarial medicine for many years in nine countries across Africa and Asia. More »

 

Shire's CFO resigns to join plant technology start-up

LONDON (Reuters) - Pharmaceutical company Shire said its chief financial officer Jeff Poulton will stand down at the end of the year to join Indigo Ag, a Boston-based start-up that seeks to improve agricultural productivity. More »

 

News, Photo and Web Search